Thomas Joos referiert beim Biomarkers in Drug Discovery & Development am 11. September in Berlin.
Sein Vortrag geht über: Overview of new Proetomic technologies for biomarker discovery. What are the opportunities and limitations to these technologies? Challenges for biomarker validation.